Wells' Criteria for Pulmonary Embolism

Wells' Criteria for Pulmonary Embolism

Assesses pretest probability of pulmonary embolism

Wells' Criteria for Pulmonary Embolism

Wells' Criteria for Pulmonary Embolism

Assesses pretest probability of pulmonary embolism

Clinical signs and symptoms of DVT (leg swelling and pain with palpation of the deep veins)
PE is the most likely diagnosis compared to an alternative diagnosis
Heart rate > 100 beats/min
Immobilization or surgery in the previous four weeks
Previous DVT or PE
Hemoptysis
Active cancer (treatment ongoing, within 6 months, or palliative)
Wells' Score 0.0 Low probability (PE unlikely, consider D-dimer)
0/7 answered · tap options to update (0–12.5)

Instructions

Assess patient’s history, risk factors, and presenting symptoms. Assign points to each criterion based on Wells’ model. Add the total score and compare with the interpretation table to determine the pretest probability of PE. Use this score alongside diagnostic testing such as D-dimer or imaging.

Overview
When to use
Why use
Evidences

Interpretation

Score

3-tier model

Simplified model

≤1.5

Low probability (~10%)

PE unlikely

2–6

Moderate probability (~30%)

PE unlikely

>6

High probability (~65%)

PE likely

 

Prospective validation in ED settings showed the Wells PE score reliably stratifies pretest probability and, when combined with D‑dimer, safely excludes PE in low‑probability patients; interrater agreement supports operational use in emergency care cohorts.
https://www.sciencedirect.com/science/article/abs/pii/S0196064404003385

 

In primary care, applying the dichotomized Wells rule (PE‑unlikely ≤4) plus a negative point‑of‑care D‑dimer safely excluded PE with a 3‑month VTE failure rate of 1.5% and sensitivity 94.5%, demonstrating usefulness beyond the ED
https://pmc.ncbi.nlm.nih.gov/articles/PMC3464185/

 

Individual‑patient meta‑analysis showed that pairing a PE‑unlikely Wells score with age‑adjusted D‑dimer (age×10 µg/L for >50y) increased the proportion of patients spared imaging from 28% to 33% overall, with failure rates <3% across subgroups, and the largest efficiency gains in older adults
https://pubmed.ncbi.nlm.nih.gov/27182696/

 

Contemporary summaries of ESC guidance endorse age‑adjusted D‑dimer cutoffs with validated pretest probability tools (e.g., Wells) to safely exclude PE in low/intermediate probability patients, formalizing the age‑adjusted approach into European care pathways
https://pmc.ncbi.nlm.nih.gov/articles/PMC7284001/

Overview
When to use
Why use
Evidences

Wells’ Criteria for Pulmonary Embolism is a clinical decision-making tool developed to estimate the probability of PE in patients with suspected venous thromboembolism. Created by Dr. Philip Wells and colleagues in the late 1990s, it incorporates both objective findings and clinical judgment, such as signs of deep vein thrombosis, recent immobilization, heart rate, hemoptysis, and history of cancer. A key feature of the score is the inclusion of whether an alternative diagnosis is less likely than PE, which reflects the clinician’s gestalt.

The score stratifies patients into probability categories: low, intermediate, and highor into a simplified two-tier model of “PE unlikely” versus “PE likely.” This stratification helps guide diagnostic strategies. For example, in patients with a low Wells’ score and a negative D-dimer, PE can often be ruled out without the need for imaging. In patients with a higher score, confirmatory imaging such as CT pulmonary angiography or ventilation-perfusion scanning is recommended.

Wells’ Criteria has become a central part of diagnostic algorithms worldwide due to its simplicity, reproducibility, and evidence base. It helps reduce unnecessary imaging in low-risk patients, minimizes radiation and contrast exposure, and ensures high-risk patients undergo timely evaluation. Studies and systematic reviews have validated its accuracy, especially when combined with D-dimer testing.

Overview
When to use
Why use
Evidences

Interpretation

Score

3-tier model

Simplified model

≤1.5

Low probability (~10%)

PE unlikely

2–6

Moderate probability (~30%)

PE unlikely

>6

High probability (~65%)

PE likely

 

Prospective validation in ED settings showed the Wells PE score reliably stratifies pretest probability and, when combined with D‑dimer, safely excludes PE in low‑probability patients; interrater agreement supports operational use in emergency care cohorts.
https://www.sciencedirect.com/science/article/abs/pii/S0196064404003385

 

In primary care, applying the dichotomized Wells rule (PE‑unlikely ≤4) plus a negative point‑of‑care D‑dimer safely excluded PE with a 3‑month VTE failure rate of 1.5% and sensitivity 94.5%, demonstrating usefulness beyond the ED
https://pmc.ncbi.nlm.nih.gov/articles/PMC3464185/

 

Individual‑patient meta‑analysis showed that pairing a PE‑unlikely Wells score with age‑adjusted D‑dimer (age×10 µg/L for >50y) increased the proportion of patients spared imaging from 28% to 33% overall, with failure rates <3% across subgroups, and the largest efficiency gains in older adults
https://pubmed.ncbi.nlm.nih.gov/27182696/

 

Contemporary summaries of ESC guidance endorse age‑adjusted D‑dimer cutoffs with validated pretest probability tools (e.g., Wells) to safely exclude PE in low/intermediate probability patients, formalizing the age‑adjusted approach into European care pathways
https://pmc.ncbi.nlm.nih.gov/articles/PMC7284001/

Frequently Asked Questions

Features and Services FAQs

Discover the full range of features and services we offer and how to use them.

What are the main factors in Wells’ PE Criteria?+
How many versions exist?+
Can Wells’ score alone diagnose PE?+
Is D-dimer always needed after Wells’ score?+
What is the role of “alternative diagnosis less likely than PE”?+
Can the tool be used in pregnancy?+

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.